Today: 29 April 2026
Browse Category

NASDAQ:STOK 24 February 2026

Stoke Therapeutics stock swings premarket after Wolfe starts coverage with $40 target (STOK)

Stoke Therapeutics stock swings premarket after Wolfe starts coverage with $40 target (STOK)

Stoke Therapeutics shares dropped 1.2% to $35.80 in early premarket trading Tuesday, after a 5.7% gain the previous session. Wolfe Research began coverage with an “Outperform” rating and a $40 price target. Investors are watching for updates on the company’s Phase 3 Dravet syndrome trial with Biogen. About 21.6% of Stoke’s float is sold short, according to MarketBeat.

Stock Market Today

  • Shanti Educational Insiders Sell ₹1.6 Billion in Stock Amid Cautious Outlook
    April 28, 2026, 8:33 PM EDT. Shanti Educational Initiatives Limited (NSE:SEIL) insiders sold shares worth ₹1.6 billion in the past year, including a significant ₹226 million sale by Jaiprakash Chiripal at prices below the current ₹200 mark. Despite a 10% share price rise recently, no insider buying was recorded, signaling possible caution among management. Insider sales in the last three months totaled ₹189 million, suggesting insiders may view shares as fully valued or overvalued. However, insiders still hold 49% of the company worth about ₹16 billion, indicating long-term commitment. Investors should note insider sales can be a weak negative signal, but these moves warrant attention alongside other fundamentals.

Latest article

AST SpaceMobile Stock’s May 11 Moment: FCC Win Meets BlueBird 7 Reality

AST SpaceMobile Stock’s May 11 Moment: FCC Win Meets BlueBird 7 Reality

29 April 2026
AST SpaceMobile will hold its first-quarter update call on May 11 after winning FCC approval to deploy a 248-satellite constellation for direct-to-device service. Shares fell 6.8% Tuesday, following the loss of its BlueBird 7 satellite in a failed launch. The company expects insurance to cover the loss and is targeting 45 satellites in orbit by end-2026. Investors are watching launch progress and commercial service timing.
OpenAI Target Miss Report Sends Oracle, CoreWeave and AI Stocks Lower

OpenAI Target Miss Report Sends Oracle, CoreWeave and AI Stocks Lower

29 April 2026
Oracle shares fell 4% and CoreWeave dropped 5.9% Tuesday after a Wall Street Journal report said OpenAI missed recent revenue and user targets. Nvidia, AMD, and Arm Holdings also declined, with the iShares Semiconductor ETF down 3.7%. OpenAI denied internal divisions and said its AI coding product Codex reached 4 million users. Oracle’s credit default swaps hit a two-week high amid concern over its $300 billion cloud deal with OpenAI.
Go toTop